💊FDA PHARMA today 💊FDA PHARMA to 12/16/17 SaturdayBy Tokio X'press EMA, Pharmaceutical kyowa-kirin, Takeda
💊Kyowa Hakko Kirin，抗Ccr4人源化抗体验收申请，用于欧洲批准的Mogum Lysumab 20171027 💊Kyowa Hakko K 10/27/17 FridayBy Tokio X'press EMA, Pharmaceutical kyowa-kirin
💊Kyowa Hakko麒麟新闻，Ultragenyx和Kyowa Hakko Kirin宣布FDA接受和优先审查指定Burosumab的生物制剂许可证申请 20171010 10/11/17 WednesdayBy Tokio X'press FDA, JPN kyowa-kirin
